Why TransEnterix Is Rallying Today
In response to the company announcing the sale of its first Senhance Surgical Robotic System in the U.S., shares of TransEnterix (NYSEMKT: TRXC) rose as much as 15% in early-morning trading on Monday. Shares have since settled down but were still up 7% as of 11:40 a.m. EST.
TransEnterix announced today that Florida Hospital -- a member of one of the largest not-for-profit healthcare systems in the country -- has agreed to purchase a Senhance system. This news marks the company's first sale since the Senhance System received FDA approval about a month ago.
Here's what Dr. Steve Eubanks -- a surgeon and executive medical director at the hospital -- had to say about the purchase decision:
Source: Fool.com
